-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
NGM BIOPHARMACEUTICALS INC quarterly/annual Return On Equity history and change rate from 2018 to Q4 2023.
- NGM BIOPHARMACEUTICALS INC Return On Equity for the quarter ending 31 Dec 2023 was -77.9 %, a 37.4% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC annual Return On Equity for 2023 was -77.9 %, a 37.4% decline from 2022.
- NGM BIOPHARMACEUTICALS INC annual Return On Equity for 2022 was -56.7 %, a 72.1% decline from 2021.
- NGM BIOPHARMACEUTICALS INC annual Return On Equity for 2021 was -32.9 %, a 5.51% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)